A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

Television presenter James Corden has this week admitted to having used Ozempic as a means of losing weight, but insisted ...

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

James Corden is among the celebrities who have tried Ozempic for weight loss, but he didn’t have the life-changing results ...

Television presenter James Corden claimed the controversial drug - traditionally used to treat type II diabetes - 'didn't ...

Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer against the backdrop of surging investor enthusiasm.

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

five times that on the brand name drug,” Noom CEO Geoff Cook said of the prices for his company’s compounded semaglutide.

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had little to do with how hungry he was or wasn't.

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...